InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,949.17
(
-0.60%
)
US TECH 100
20,286.40
(
-0.99%
)
Dow Jones
43,750.86
(
-0.47%
)
Brent Oil
72.21
(
0.00%
)
Bitcoin
88,160.01
(
0.93%
)
Post# of 64738
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

thalio

Send PM Follow Ignore
Followers 13
Posts 463
Boards Moderated 0
Alias Born 07/16/2003

thalio

Re: BigB post# 7378

Tuesday, 04/27/2004 3:16:54 PM

Tuesday, April 27, 2004 3:16:54 PM

Post# of 64738
BigB - I specified otherwise untreatable infections. CYGX is targeting those as well. In fact, that's the area where they already have the most promising preclinical data.

Resistant infections (especially if they could isolate one specific type) is an indication that I believe would qualify as small enough for orphan drug status.

Th



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up